Savannah Therapeutics, Inc.

Savannah Therapeutics, Inc. (SavThera) is a Maryland-based biopolymer manufacturing company incorporated in March 2026, formed to acquire and grow the OTC wound-care product business from Medcura, Inc. Led by CEO and Co-Founder Tom Wollan, the company modifies biopolymers — including chitosan-based products like CutCure — for wound care and related applications. SavThera is a lean, early-stage team currently building out its operations, quality systems, and commercial partnerships.